Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
An announcement from Grace Therapeutics ( (GRCE) ) is now available.
Grace Therapeutics, Inc. has filed a Form S-3 registration statement with the Securities and Exchange Commission, allowing the company to offer securities on a delayed or continuous basis. This strategic move is aimed at providing the company with financial flexibility to support its growth and operational objectives, potentially impacting its market positioning and offering new opportunities for stakeholders.
More about Grace Therapeutics
Grace Therapeutics, Inc. operates in the pharmaceutical industry, focusing on the development and commercialization of innovative therapies. The company is based in Princeton, New Jersey, and is known for its commitment to advancing medical treatments.
YTD Price Performance: -36.50%
Average Trading Volume: 88,818
Technical Sentiment Consensus Rating: Strong Buy
Current Market Cap: $34.08M
See more insights into GRCE stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue